Krishna Athmakuri: Evaluating Left Atrial Appendage Occlusion Against Oral Anticoagulation
Krishna Athmakuri, Research Trainee at Mayo Clinic, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in EP Europace, adding:
“I am incredibly honoured to share that our Bayesian meta-analysis comparing left atrial appendage occlusion (LAAO) versus oral anticoagulation (OAC) has been published in the prestigious EP Europace.
Our analysis revisits the non-inferiority conclusions of the pivotal LAAO trials through a Bayesian framework. The findings suggest that the available evidence may not support the claimed non-inferiority of LAAO to OAC as confidently as previously believed.
The posterior probabilities of non-inferiority revealed through a Bayesian framework highlight this uncertainity.
This honour is surpassed only by the fact that our paper was cited and discussed in an editorial published in EP Europace. Having our work recognised on such a prestigious platform is both immensely gratifying and deeply humbling.
I am immensely grateful to my mentors Komandoor Srivathsan, Hari Chaliki, co-authors Shreyas Raghavan Nandyal, Hrushikesh Reddy, Saketh Vinjamuri, Shanmukh Lingamsetty, Anushka Mahajan, Muqaddas Hussain for their guidance, support, and contributions throughout this project.”
Title: Comparative evaluation of left atrial appendage occlusion and oral anticoagulation
Authors: Krishna Saketh Athmakuri , Shreyas Raghavan Nandyal , Hrushikesh Reddy Pamreddy , Saketh Vinjamuri , Shanmukh S P Lingamsetty , Anushka Vishwas Mahajan , Muqaddas Hussain , Hari P Chaliki , Komandoor Srivathsan

Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian